Stay updated with breaking news from Oriciro Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Viral Vectors and Plasmid DNA Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. Substantial Growth...
Moderna expects to launch several products over the next few years.
First quarter 2023 revenues of $1.9 billion; GAAP net income of $79 million and GAAP diluted EPS of $0.19Company in negotiations for new orders for fall of 2023 in U.S., Japan, and EU, in addition to reiterating
Company in negotiations for new orders for fall of 2023 in U.S., Japan, and E.U., in addition to reiterating 2023 minimum sales expectations of approximately $5.0 billion from previously... | May 4, 2023
MRNA pioneer Moderna wants to grow and thrive past its initial COVID-19 vaccine success. “To continue to build the best version of Moderna, we have established seven priorities for 2023,” says CEO Stephane Bancel: as the company outlines goals that range from embracing AI to a 'bold campaign' of cancer vaccine studies.